Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT00516217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: galiximab

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]